SEARCH

SEARCH BY CITATION

References

  • 1
    Schoenwetter WF. Allergic rhinitis: epidemiology and natural history. Allergy Asthma Proc 2000;21:16.
  • 2
    Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998;81:478518.
  • 3
    Young T, Finn L, Kim H. Nasal obstruction as a risk factor for sleep-disordered breathing. J Allergy Clin Immunol 1997;99:S757S762.
  • 4
    Blaiss MS. Cognitive, social, and economic costs of allergic rhinitis. Allergy Asthma Proc 2000;21:713.
  • 5
    Wilken J. Decrements in cognitive functioning associated with seasonal allergic rhinitis. Allergy 2000;55 Suppl 63:193.
  • 6
    Rachelefsky GS. National guidelines needed to manage rhinitis and prevent complications. Ann Allergy Asthma Immunol 1999;82:296305.
  • 7
    American Academy of Allergy Asthma and Immunology. The allergy report. Vol. 1. Overview of allergic diseases. Milwaukee, WI: American Academy of Allergy, Asthma, and Immunology, 2000.
  • 8
    Bronsky E, Boggs P, Findlay S, et al. Clinical aspects of allergic disease: comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis. J Allergy Clin Immunol 1995;96:139147.
  • 9
    Hendeles L. Selecting a decongestant. Pharmacotherapy 1993;13:129S134S.
  • 10
    Meltzer EO, Prenner BM, Nayak A. Efficacy and tolerability of once-daily 5 mg desloratadine, an H1-receptor antagonist, in patients with seasonal allergic rhinitis. Assessment during the spring and fall allergy seasons. Clin Drug Invest 2001;21:2532.
  • 11
    Ring J, Hein R, Gauger A, Bronsky E, Miller B. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Int J Dermatol 2001;40:17.
  • 12
    Agrawal DK, Berro A, Kreutner W, Townley RG. Anti-inflammatory properties of desloratadine (DCL): effect on eosinophil chemotaxis, adhesion and release of superoxide anions. J Allergy Clin Immunol 2000;104(1, Pt 2):S16S17.
  • 13
    Kreutner W, Hey JA, Anthes J, Barnett A, Young S, Tozzi S. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects. Arzneimittelforschung 2000;50:345352.
  • 14
    Kreutner W, Hey JA, Chiu P, Barnett A. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 2nd communication: lack of central nervous system and cardiovascular effects. Arzneimittel-forschung 2000;50:441448.
  • 15
    Scharf MB, Kay GC, Rikken G, Danzig MR, Staudinger H. Desloratadine has no effect on wakefulness or psychomotor performance. Allergy 2000;55 Suppl 63:280280.
  • 16
    Affrime MB, Banfield C, Glue P, et al. Lack of electrocardiographic effects when desloratadine and ketoconazole are coadministered. Allergy 2000;55 Suppl 63:277277.
  • 17
    Glue P, Banfield C, Affrime MB, Statkevich P, Reyderman L, Padhi D. Desloratadine and erythromycin: pharmacokinetics and electro-cardiographic pharmacodynamic effects. J Allergy Clin Immunol 2000;104(1, Pt 2):S387S387.
  • 18
    Hey J, Anthes J, Barnett A, Tozzi S, Kreutner W. Preclinical cardiovascular and CNS safety profile of desloratadine, a selective and nonsedating histamine H1-receptor antagonist. J Allergy Clin Immunol 2000;104 (1 Pt 2):S383.
  • 19
    Settipane RA. Complications of allergic rhinitis. Allergy Asthma Proc 1999;20:209213.
  • 20
    McNicholas WT, Tarlo S, Cole P, et al. Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis 1982;126:625628.
  • 21
    Shturman-Ellstein R, Zeballos RJ, Buckley JM, Souhrada JF. The beneficial effect of nasal breathing on exercise-induced bronchoconstriction. Am Rev Respir Dis 1978;118:6573.
  • 22
    Cheng MC, Enlow DH, Papsidero M, Broadbent BH Jr, Oyen O, Sabat M. Developmental effects of impaired breathing in the face of the growing child. Angle Orthod 1988;58:309320.
  • 23
    Van Cauwenberge P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis. Allergy 2000;55:116134.DOI: 10.1034/j.1398-9995.2000.00526.x